Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|15|14|1322-1330
ISSN： 1389-4501
Source： Current Drug Targets, Vol.15, Iss.14, 2014-12, pp. : 1322-1330
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Access to resources
Recommend
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :
Erlotinib improves QOL in NSCLC
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Colorectal cancer in review: the role of the EGFR pathway
Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. :